Health Care: Drugs

United Therapeutics Corp (UTHR: NASDAQ)

$172.96 n/a | n/a%
03/27/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 172.96
52 Week High 181.61
52 Week Low 84.63
Avg. Daily Vol. (Mil) 0.60
Beta (3 year) 1.32
Share Related Items
Mkt Cap (Mil) 8,071.27
Shares Out (Mil) 46.67
Float (Mil) 36.05
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.70
Current Ratio 1.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.10
Valuation Ratios
Price Earnings 27.50
Price/Sales 6.26
Price/Book 6.50
Price/Cash Flow 20.70
Per Share Data
Earnings 6.28
Sales 27.61
Book Value 26.62
Cash Flow 8.36
Business Summary
United Therapeutics Corp is a biotechnology company. The Company is engaged in thedevelopment and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.
General Information
1040 Spring Street
Silver Spring, MD 20910
www.unither.com
Industry : Drugs
Sector: Health Care
Employees: 740
CEO: Roger A. Jeffs,PhD
Short Interest
Current Month (Mil) 4.94
Previous Month (Mil) 4.48
Short Interest Ratio (Days) 7.90
Management Effectiveness
Return on Equity 27.40
Return on Assets 18.00
Return on Investments 27.40
Profitability
Gross Margin 94.10
EBIT Margin 42.10
Profit Margin 26.40

Portfolios with UTHR

Latest UTHR Headlines from TheStreet

More Financial News for UTHR

Press Releases for UTHR

See All Press Releases

Partner Headlines for UTHR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter